We are live on ! Find out more
NXTC icon

NextCure

59 hedge funds and large institutions have $64.3M invested in NextCure in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 22 increasing their positions, 16 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 16

5% less call options, than puts

Call options by funds: $246K | Put options by funds: $258K

4.29% less ownership

Funds ownership: 52.04% → 47.74% (-4.3%)

17% less funds holding

Funds holding: 71 → 59 (-12)

67% less capital inflows, than outflows

Capital inflows: $3.26M | Capital outflows: $10M

80% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 15

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
59
Holders Change
-12
Holders Change %
-16.9%
% of All Funds
0.93%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
3
Increased
22
Reduced
16
Closed
15
Calls
$246K
Puts
$258K
Net Calls
-$12K
Net Calls Change
-$264K

NXTC Hedge Fund Activity: Q1 2022 in Review

59 of the 6,365 institutional investors tracked by Wall St. Rank reported a position in NextCure (NXTC) for Q1 2022, worth a combined $64.3M — down 25% from $86.2M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of NXTC and 3 opened new positions — a net loss of 12 holders — while 16 trimmed existing stakes and 22 added.

The largest buyer was Dimensional Fund Advisors, adding an estimated $773K. The largest seller was Woodline Partners, cutting an estimated $3.1M.

  • 59 institutional investors held NextCure (NXTC) as of Q1 2022, down from 71 in Q4 2021.
  • Funds reported $64.3M of NextCure stock for Q1 2022, down 25% quarter-over-quarter.
  • 3 funds opened new NextCure positions in Q1 2022 and 15 closed out, a net change of -12 holders.
  • The largest NextCure buyer in Q1 2022 was Dimensional Fund Advisors, an estimated $773K added.
  • The largest NextCure seller in Q1 2022 was Woodline Partners, an estimated $3.1M sold.

Based on aggregated 13F filings for Q1 2022.